Frolov V M, Rychnev V E
Antibiot Med Biotekhnol. 1985 May;30(5):375-8.
Two hundred and six patients with erysipelas were examined. Of these, 100 patients were subjected to the routine therapy and 106 were additionally treated with methyluracil and prodigiosan. It was noted that the use of methyluracil and prodigiosan in the combined treatment of erysipelas promoted an increase in the efficacy of the antibiotic therapy owing to acceleration of the local inflammation regression and the favourable effect of the treatment on the cell immunity.